TY - JOUR
AU - Regnier,  B.
AB -  Letters Eur. J. Clin. Microbiol. Infect. Dis. 4. Taylor DN, Pitarangsi C, Echeverria P, Dinega BM: Campylobacter enteritis during doxycycline prophylaxis for malaria in Thailand. Lancet 1988, ii: 578-579. 5. DuPont HL, Ericsson C: Prevention and treatment of traveller's diarrhoea. New England Journal of Medicine 1993, 328: 1821-1827. 6. Kuschner RA, Trofa AF, Thomas RJ, Hoge CW, Pitarangsi C, Amato S, Olafson RP, Echeverria P, Sadoff JC, Taylor DN: Use of azithromycin for the treatment of CampyIobacter enteritis in travellers to Thailand, an area where ciprofloxacin resistance is prevalent. Clinical Infectious Diseases 1995, 21: 536-541. 7. Sjogren E, Kaijser B, Werner M: Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coil isolated in Sweden: a 10-year follow-up report. Antimicrobial Agents and Chemotherapy 1992, 36: 2847-2849. 8. Hirschl AM, Wolf D, Berger J, Rotter ML: In vitro suscep~ tibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin. Zentratbtatt for Bakteriologie 1990, 272: 443-447. 9. Rautelin H, Renkonen OV, Kosunen TU: Emergence of fluoroquinolone resistance in Campylobacterjejuni and Campylobacter coli in subjects from Finland. Antimicrobial Agents and Chemotherapy 1991, 35: 2065-2069. 10. Gomez-Garces JL, Cogollo R, Alos Jl: Susceptibilities of fluoroquinolone-resistantstrains of Campylobacterjejuni to 11 oral 
TI - Torsades de pointe probably related to sparfloxacin
JF - European Journal of Clinical Microbiology Infectious Diseases
DO - 10.1007/BF01695673
DA - 1996-04-01
UR - https://www.deepdyve.com/lp/springer-journals/torsades-de-pointe-probably-related-to-sparfloxacin-ySmAKrdGLS
SP - 350
EP - 351
VL - 15
IS - 4
DP - DeepDyve
ER -